These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19519731)

  • 1. Intravitreal bevacizumab for neovascular glaucoma.
    Jonas JB; Golubkina L; Libondi T; Rensch F
    Acta Ophthalmol; 2010 Mar; 88(2):e22-3. PubMed ID: 19519731
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal bevacizumab for neovascular glaucoma.
    Andrijević-Derk B; Vatavuk Z; Bencić G; Novak-Laus K; Mandić Z
    Acta Clin Croat; 2008 Sep; 47(3):175-9. PubMed ID: 19175068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior ciliary artery ligation with simultaneous intravitreal bevacizumab: an adjuvant treatment for end-stage neovascular glaucoma.
    Ghaffariyeh A; Honarpisheh N
    Acta Ophthalmol; 2010 Jun; 88(4):e133. PubMed ID: 19558574
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of intravitreal bevacizumab in neovascular glaucoma: a case report.
    Kelkar AS; Kelkar SB; Kelkar JA; Nagpal M; Patil SP
    Bull Soc Belge Ophtalmol; 2007; (303):43-5. PubMed ID: 17894286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab in a patient with neovascular glaucoma.
    Kahook MY; Schuman JS; Noecker RJ
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):144-6. PubMed ID: 16583637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
    Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
    J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
    Ouhadj O; Chergui I; Mendil L; Nouri MT
    J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
    J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
    Yazdani S; Hendi K; Pakravan M
    J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma.
    Yokoyama K; Choshi T; Kimoto K; Shinoda K; Nakatsuka K
    Acta Ophthalmol; 2008 Dec; 86(8):927-8. PubMed ID: 18494739
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results in neovascular glaucoma treatment].
    Macarie SS; Macarie D
    Oftalmologia; 2011; 55(2):98-100. PubMed ID: 21888077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
    dell'Omo R; Kulkarni A; Franks WA
    Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal injection of bevacizumab to treat neovascular glaucoma.
    Kubota T; Aoki R; Harada Y; Tou N; Tawara A
    Jpn J Ophthalmol; 2008; 52(5):410-412. PubMed ID: 18991046
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy and safety of intravitreal injection of bevacizumab in the treatment of neovascular glaucoma: systematic review].
    Martínez-Carpio PA; Bonafonte-Márquez E; Heredia-García CD; Bonafonte-Royo S
    Arch Soc Esp Oftalmol; 2008 Oct; 83(10):579-88. PubMed ID: 18855277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration].
    Geitzenauer W; Michels S; Prager F; Kornek G; Vormittag L; Rosenfeld P; Schmidt-Erfurth U
    Klin Monbl Augenheilkd; 2006 Oct; 223(10):822-7. PubMed ID: 17063425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
    Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
    J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma.
    Ghosh S; Singh D; Ruddle JB; Shiu M; Coote MA; Crowston JG
    Clin Exp Ophthalmol; 2010 May; 38(4):353-7. PubMed ID: 20665941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intravitreal bevacizumab in neovascular glaucoma.
    Gheith ME; Siam GA; de Barros DS; Garg SJ; Moster MR
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):487-91. PubMed ID: 17900231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
    Kitnarong N; Chindasub P; Metheetrairut A
    Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.